Gene-modified nonhuman animal model
AssigneeHamamatsu Photonics K.K.
InventorsIori OHMORI, Mamoru OUCHIDA, Tomoji MASHIMO
Life of this patent
Estimating the term…
Loading patent…
AssigneeHamamatsu Photonics K.K.
InventorsIori OHMORI, Mamoru OUCHIDA, Tomoji MASHIMO
Estimating the term…
Provided is a nonhuman animal model that is obtained by modifying a gene encoding thioredoxin and useful as a disease model of aging, kidney diseases, cardiovascular diseases, hypertension, aortic dissection, chronic obstructive lung disease, age-dependent epilepsy, abnormality of lipid metabolism, anemia, osteoporosis, abnormal immunity, etc. These variety of phenotypes are caused by the fact that a modification of a gene encoding thioredoxin induces hypofunction of thioredoxin expressed in multiple organs throughout the body. The gene encoding thioredoxin is a gene selected from among TXN, TRX, TRX1, RRDX, Txn1, Txn, Trx1 and ADF.
A non-human model animal in which a gene encoding thioredoxin is modified.
(canceled)
Dependencies are inferred from the claim text.